Mucin type O-glycosylation begins with the transfer of GalNAc to serine and threonine residues on proteins by a family of UDP-GalNAc:polypeptide N-acetylgalactosaminlytransferases. These enzymes all contain a lectin-like (QXW) 3 repeat sequence at the C terminus that consists of three tandem repeats (␣, ␤, and ␥). The putative lectin domain of one of the most ubiquitous isozymes, GalNAc-T1, is reportedly not functional. In this report, we have reevaluated the role of the GalNAc-T1 lectin domain. Deletion of the lectin domain resulted in a complete loss of enzymatic activity. We also found that GalNAc-T1 has two activities distinguished by their sensitivities to inhibition with free GalNAc; one activity is sensitive, and the other is resistant. In our experiments, the former activity is represented by the O-glycosylation of apomucin, an acceptor that contains multiple glycosylation sites, and the latter is represented by synthetic peptides that contain a single glycosylation site. Site-directed mutagenesis of the lectin domain selectively reduced the former activity and identified Asp 444 in the ␣ repeat as the most important site for GalNAc recognition. A further reduction of the GalNAc-inhibitable activity was observed when both Asp 444 and the corresponding aspartate residues in the ␤ and the ␥ repeats were mutated. This suggests a cooperative involvement of each repeat unit in the glycosylation of polypeptides with multiple acceptor sites.
O-Glycosidically linked oligosaccharides, called mucin-type oligosaccharides, are linked to polypeptides through an ␣-linkage (GalNAc␣1 3 Ser (or Thr)) and are known to occur on mucins as well as on other secretory and membrane glycoproteins (1) . The initial step in the biosynthesis of these structures is catalyzed by a group of enzymes known as the UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferases (GalNActransferases). 1 These enzymes transfer GalNAc from the nucleotide-sugar donor, UDP-GalNAc, to certain serine and threonine residues on acceptor proteins (2) (3) (4) . Recent progress in the molecular cloning of GalNAc-transferases has revealed a large gene family, with 10 distinct isozymes identified to date (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . All cloned GalNAc-transferases are type II membrane proteins (17) with a common domain structure that includes a short N-terminal cytoplasmic tail, a transmembrane domain, a stem domain, a putative catalytic domain, and C-terminal (QXW) 3 repeats. The luminal, putative catalytic domain of the GalNAc-transferases consists of two conserved subdomains, termed the glycosyltransferase 1 (GT1) motif and the Gal/ GalNAc-transferase motif (18) . The exact roles of these domains in catalysis are not clear. However, recent reports have revealed some interesting possibilities, including a demonstration of a specific interaction of the GT1 motif with UDP-GalNAc (19) and the possible involvement of the Gal/GalNAc-transferase motif in the catalytic activity (18) .
The C-terminal (QXW) 3 repeats occur exclusively in the GalNAc-transferases (20) . This domain, which consists of three tandem repeats (␣, ␤, and ␥) with ϳ50 amino acid residues in each repeat unit, is homologous to the B-chain in the plant lectin ricin (20) . Hence, it is assumed that the (QXW) 3 repeats of the GalNAc-transferases can function as a lectin, although no direct sugar binding activity has been demonstrated. X-ray crystallography studies have revealed distinct features of the ricin molecular structure (21) (22) (23) . Each repeat unit in the molecule has a unique, globular structure with several conserved hydrophobic amino acids at the core. Moreover, the cysteine residues in the repeats are essential for proper folding, and several amino acid residues in the molecule have been shown to interact with the haptenic monosaccharide, galactose. There is no information available about the three-dimensional structures of the (QXW) 3 repeats in the GalNAc-transferase lectin domains. However, computer-based analysis predicts conformational similarity with the ricin lectin domain (24, 25) . Until recently, the function of the GalNAc-transferase lectin domain remained largely unknown. However, recent work has demonstrated the importance of this domain for GalNAc-T4, an isozyme that requires prior O-glycosylation of the acceptor peptides for catalytic activity (26, 27) . In contrast, glycosylation by GalNAc-T1, one of the most ubiquitous isozymes, is considered independent of the (QXW) 3 repeats, since the mutations in this domain resulted in no effects or only modest effects on the activity (18) . In this report, we have reevaluated the functional role of the GalNAc-T1 lectin domain, and we demonstrate that this domain is involved in glycosylation of polypeptides with multiple acceptor sites. Detailed information on the structurefunction relationship of the lectin domain is also presented. The plasmid, pInsProA⌬N42, containing cDNA for soluble, tagged, rat GalNAc-T1 was prepared by deleting the coding sequence for the cytoplasmic tail and the transmembrane domain from full-length GalNAc-T1 cDNA, and by fusing cDNA for an insulin signal sequence and a Protein A-IgG binding domain to the resulting 5Ј-end of the truncated GalNAc-T1 cDNA (Fig. 1A) , as described previously (19) . Site-directed mutagenesis on pInsProA⌬N42 was performed using primers listed above (19) . The nucleotide sequence of the mutant clones was verified by DNA sequencing using ALFexpress II (Amersham Biosciences).
Expression of P-⌬N42 and Mutant P-⌬N42 in COS7 Cells-The fusion protein (P-⌬N42), containing a Protein A-IgG binding domain at the N terminus, and mutant P-⌬N42 were expressed in COS7 cells and purified from the conditioned medium as described previously (19) . SDS-PAGE and Western blotting of the recombinant molecules were also carried out as described (19) . The protein bands on the immunoblots were scanned and quantitated with a Luminoimage Analyzer LAS-1000 PLUS (Fujifilm). The activities of P-⌬N42 and mutant P-⌬N42 were determined as described below, and the activity levels were corrected for the enzyme protein concentration in the medium.
Preparation and Expression of H-⌬N32 and H-⌬N32⌬C130
-A truncated form of rat GalNAc-T1, lacking the 32 N-terminal amino acid residues, including the cytoplasmic tail and the transmembrane domain, was amplified by PCR, using full-length GalNAc-T1 cDNA, cloned in pcDNA3.1, as a template. For this reaction, the primer set, MEcoT22I-GNT1 and 3.1R, was used. A truncated form of rat GalNAc-T1, lacking the 32 N-terminal (including the cytoplasmic and transmembrane domains) and the 130 C-terminal amino acid residues (including the (QXW) 3 repeats), was amplified by PCR using the primer set, MEcoT22I-GNT1 and DC130. PCR was carried out with KOD dash DNA polymerase for 30 cycles of 96°C for 30 s, 50°C for 30 s, and 72°C for 2 min. The PCR products were purified and ligated into the pGEM-T easy (Promega) to generate plasmids containing the truncated GalNAc-T1 cDNAs (p⌬N32 and p⌬N32⌬C130). A synthetic linker fragment, encoding His and hemagglutinin (HA) tags (HHHHHHGGYPY-DVPDYAGG) with BamHI and EcoRI restriction sites at the 5Ј-and 3Ј-ends, respectively, was inserted into the BamHI-EcoRI sites of pAcGP67A (a baculovirus transfer vector) to produce the vector, pAcGP67A-His/HA. pAcGP67A-His/HA contains His and HA tag sequences, downstream of a secretion signal sequence and a signal peptide cleavage site, such that the in-frame ligation of a cDNA encoding a protein of interest leads to the production of a secreted protein with a His and an HA tag at the N terminus. p⌬N32 and p⌬N32⌬C130 were digested with EcoT22I, and the coding sequences for ⌬N32 and ⌬N32⌬C130 were subcloned into the PstI sites of pAcGP67A-His/HA, generating the plasmids pAcGP67A-His/HA/⌬N32 and pAcGP67A-His/HA/⌬N32⌬C130, for expression of secreted, truncated rat GalNAc-T1 fused to His and HA tags (H-⌬N32 and H-⌬N32⌬C130). Sf9 cells were grown at 27°C in TMN-FH medium (Pharmingen) containing 10% fetal calf serum. Co-transfection of Sf9 cells, with the plasmid (pAcGP67A-His/HA/⌬N32 or pAcGP67A-His/HA/⌬N32⌬C130) and Baculo-Gold TM DNA (Pharmingen), was performed according to the manufacturer's specifications. Briefly, 0.4 g of pAcGP67A-His/HA/ ⌬N32 or pAcGP67A-His/HA/⌬N32⌬C130 was mixed with 0.1 g of Baculo-Gold TM DNA and then co-transfected into Sf9 cells in 24-well plates. Five days after transfection, recombinant viruses were collected from the culture medium. To prepare large virus stocks, the recombinant viruses were inoculated in Sf9 cells with multiplicity of infection of 0.01, and the culture media were harvested after 3-5 days. For the expression of H-⌬N32 and H-⌬N32⌬C130, recombinant viruses were inoculated into Sf9 cells with a multiplicity of infection of 5. After 3-5 days, the culture medium containing the recombinant proteins was collected.
Binding Assay with UDP-Hexanolamine-Agarose and ApomucinSepharose-To assess binding activity with UDP, conditioned medium containing either H-⌬N32 or H-⌬N32⌬C130 was mixed with 20 l of UDP-hexanolamine-agarose, in 600 l of Buffer A (25 mM imidazoleHCl buffer, pH 7.2, containing 20 mM MnCl 2 and 100 mM NaCl), and incubated by rocking, at 4°C, for 2 h. Following centrifugation at 2,500 rpm for 5 min, the supernatant was recovered, and the resin was washed with Buffer A. The supernatants were combined and referred to as the unbound fraction. The resin was washed twice with Buffer B (25 mM imidazole-HCl buffer, pH 7.2, containing 20 mM MnCl 2 , 1 M NaCl, and 0.1% Triton X-100). Adsorbed proteins were eluted by washing the resin twice with Buffer C (25 mM imidazole-HCl buffer, pH 7.2, containing 1 M NaCl and 50 mM EDTA). Finally, strongly bound proteins that were not eluted with EDTA were released by boiling the resin in SDS-PAGE sample buffer. Mutant GalNAc-T1 proteins in each fraction were immunoprecipitated by incubating with an anti-His 6 tag antibody (Invitrogen) and Protein-G Sepharose. The precipitated proteins were analyzed by SDS-PAGE, followed by Western blotting using polyvinylidene difluoride membranes. The recombinant proteins on the membrane were probed with anti-HA 3F10 antibodies conjugated with peroxidase (Roche Molecular Biochemicals) and visualized using the ECL Western blotting analysis system from Amersham Biosciences. Control experiments were carried out as described above, with the exception that the conditioned media containing H-⌬H32 or H-⌬H32⌬C130 were preincubated with either 2 mM UDP or 50 mM GDP in 600 l of Buffer A for 30 min at 4°C, before adding 20 l of UDP-hexanolamine-agarose to the incubation mixture. In the binding experiments with apomucinSepharose, samples containing either H-⌬N32 or H-⌬N32⌬C130 were fractionated in a similar fashion with the exception that Buffers A and B contained 0.25 mM UDP. Proteins recovered from each fraction were analyzed by SDS-PAGE followed by Western blotting and detection by ECL.
GalNAc-transferase Assay-GalNAc-transferase assays using apomucin as acceptor were carried out as described previously (19) . In assays using a peptide acceptor, the reaction was carried out in an incubation mixture composed of Buffer D (50 mM imidazole-HCl buffer, pH 7.2, containing 10 mM MnCl 2 , 0.1% Triton X-100, and 6 nmol of UDP-[
3 H]GalNAc with ϳ30,000 dpm) containing 0.5 g of PPDAATA-APL or GVVPTVVPG and an appropriate amount of enzyme in a total volume of 40 l. The mixture was incubated at 37°C for 0 -16 h, and the reaction was stopped by adding 10 l of 0.25 M EDTA. The reaction products were subsequently separated on C 18 cartridges (Varian), as described (29) . Kinetic analysis of P-⌬N42 and its mutants were carried out as described previously (19) . 3 Repeats on GalNAc-T1 Activity-A secreted fusion protein (P-⌬N42), composed of a truncated rat GalNAc-T1 sequence with a Protein A-IgG binding domain fused to the N terminus, was expressed in COS7 cells. P-⌬N42 retained full activity and generated the same K m values for donor and acceptor substrates as the full-length enzyme (19) . Consequently, it was used for the following studies.
RESULTS

Effect of Deletion of the (QXW)
To investigate the role of the GalNAc-T1 (QXW) 3 repeats in catalysis, we prepared three deletion mutants, P-⌬N42⌬C45, P-⌬N42⌬C85, and P-⌬N42⌬C130, in which the ␥ repeat unit, the ␥ and ␤ repeat units, and the entire (QXW) 3 repeat domain were deleted, respectively (Fig. 1 ). The mutant P-⌬N42 molecules as well as intact P-⌬N42 were subsequently expressed in COS7 cells, the secreted fusion proteins were isolated from the culture medium, and their activities were determined, using deglycosylated bovine submaxillary mucin (apomucin) as acceptor. Previous work has demonstrated that bovine submaxillary apomucin is an efficient substrate of GalNAc-T1 (30) . The molecule is characterized by a high content of serine, threonine, and proline residues and as a consequence contains a large number of putative sites for O-glycosylation (31) (32) (33) (34) . Chemical analysis of the apomucin preparation used in this investigation failed to detect any remaining GalNAc, indicating that virtually all of the GalNAc residues were released from the mucin molecule. The secreted fusion proteins were quantified by Western blotting, as described under "Experimental Procedures." Their enzymatic activities were corrected for the levels of enzyme protein and expressed as relative to that of P-⌬N42 such that the effect of each mutation on the enzymatic activity could be evaluated. Western blotting of the COS7 cell-produced proteins showed that their molecular weights correlated well with the degree of the truncation and also that the expression levels of all of the mutant proteins were significantly decreased, as compared with P-⌬N42 (Fig. 1) . Moreover, the enzymatic activities of the mutant proteins were reduced to almost background level. This suggests that the (QXW) 3 repeats are important for stable expression and/or secretion as well as for the enzymatic activity of GalNAc-T1.
To assess the importance of the C-terminal sequence for the activity of GalNAc-T1, the deletion mutants P-⌬N42⌬C1, P-⌬N42⌬C3, P-⌬N42⌬C9, and P-⌬N42⌬C12 were generated ( Fig. 2A ). As shown in Fig. 2B , P-⌬N42⌬C1 and P-⌬N42⌬C3 were fully active, whereas the activity of P-⌬N42⌬C9 was about 50% of that of P-⌬N42. Interestingly, the deletion of 12 amino acid residues from the C terminus (P-⌬N42⌬C12) resulted in complete inactivation of P-⌬N42. The reason for the inactivation of this mutant enzyme is not clear, but it may be related to the loss of Trp 548 . This tryptophan residue is conserved in ricin and in all GalNAc-transferases cloned to date. Moreover, it is reported to be essential for the formation of the hydrophobic core in the globular lectin domain (21) (22) (23) (24) . It is likely that these disulfide bonds stabilize the globular conformation of each unit. To examine whether disruption of the disulfide bonds in the repeats affects the enzymatic activity, we prepared mutant constructs for each cysteine residue in the (QXW) 3 repeat domain. Fig. 3B shows that all the mutant proteins generated were completely inactive. Moreover, their expression levels were significantly decreased. Consistent with the results from our constructs with deleted (QXW) 3 repeats (see above), this again indicates that the integrity of this domain is important for GalNAc-T1 activity.
Binding of the C-terminal Deletion Mutant to UDP-Hexanolamine-Agarose and Apomucin-Sepharose-The inactivation of P-⌬N42, caused by truncation of the (QXW) 3 repeats or disruption of the disulfide bonds in the (QXW) 3 repeats, may result either from a conformational change in the entire enzyme molecule or from malfolding of the C-terminal repeat domain. To evaluate the effects of deletion of the C-terminal domain, we compared the UDP binding activities of the GalNAc-T1 mutants. As reported previously, GalNAc-T1 primarily recognizes the UDP portion of UDP-GalNAc (2, 19) . In fact, UDP affinity chromatography has been used successfully for purification of GalNAc-transferases (35, 36) . To investigate the capacity of the mutant enzymes for nucleotide sugar binding, we generated the GalNAc-T1 mutant enzymes, H-⌬N32 and H-⌬N32⌬C130 that, instead of a large Protein A-IgG binding domain, have a His tag and an HA epitope tag (19 amino acid residues in total) fused to the N terminus (Fig. 4A) . This was done because our preliminary binding experiments demonstrated that enzymat-
FIG. 1. Expression and enzymatic activity of the (QXW) 3 deletion mutants.
A, schematic representation of wild type and mutant GalNAc-T1. B, enzymatic activity of mutant GalNAc-T1 enzymes. The mutant enzymes were expressed in COS7 cells, and the secreted recombinant proteins were recovered from the culture medium. The amount of the secreted protein was determined by Western blotting followed by densitometric scanning of the blot (lower panel). The enzymatic activity secreted in the medium was determined using apomucin as acceptor, corrected for the amount of the enzyme protein in the medium, and expressed as activity relative to that of P-⌬N42. Solid bars, mutant enzymes; hatched bar, P-⌬N42.
FIG. 2. Enzymatic activity of C-terminal deletion mutant enzymes.
A, C-terminal amino acid sequence of GalNAc-T1. The C terminus of each deletion mutant is indicated by an arrow. B, enzymatic activity of the C-terminal deletion mutants. Enzyme assay and Western blotting of the expressed mutants were carried out as described in the legend to Fig. 1 . Solid bars, mutant enzymes; hatched bar, P-⌬N42.
ically active P-⌬N42 failed to bind to UDP-hexanolamine-agarose, whereas P-⌬N42⌬C130 retained capacity for binding (data not shown). We considered it possible that the large Protein A-IgG binding domain (ϳ30 kDa) in P-⌬N42 (Fig. 1A ) could sterically interfere with the binding to UDP immobilized on agarose. Deletion of the entire C-terminal lectin domain might mitigate this steric hindrance, thereby making retention of P-⌬N42⌬C130 on the UDP-hexanolamine-agarose possible. The His/HA tag fusion constructs were expressed as secreted proteins in insect cells, using the baculovirus expression system. The secreted molecules were purified with Ni ϩ -chelating chromatography and assayed for enzymatic activity. Whereas H-⌬N32 was enzymatically active at levels similar to P-⌬N42, H-⌬N32⌬C130 was inactive. This was also the case for P-⌬N42⌬C130. Culture media containing either H-⌬N32 or H-⌬N32⌬C130 were mixed with UDP-hexanolamine-agarose. Following incubation, the suspension was centrifuged to obtain fractions containing UDP-hexanolamine-unbound (the supernatant) and UDP-hexanolamine-bound (the resin) material. The UDP-hexanolamine-bound fraction was washed with the buffer containing 1 M NaCl and 0.1% Triton X-100. The adsorbed proteins on the resin were then eluted by chelating Mn 2ϩ , a metal ion essential for donor substrate binding, with EDTA. H-⌬N32 or H-⌬N32⌬C130 recovered in the bound and unbound fractions was immunoprecipitated with an anti-His 6 tag antibody, subjected to SDS-PAGE, and analyzed by Western blotting, using a peroxidase-conjugated anti-HA-antibody. Adsorbed proteins not eluted with EDTA were released by boiling the resin in the SDS-PAGE sample buffer. In contrast to the results from the constructs containing a Protein A-IgG binding domain, both H-⌬N32 and H-⌬N32⌬C130 were capable of binding to UDP-hexanolamine-agarose (Fig. 4B) . H-⌬N32 appeared to bind stronger than H-⌬N32⌬C130. Still, small amounts of the recombinant proteins were also found in the unbound fractions. This may represent denatured proteins, since no enzymatic activity was detected in these fractions (data not shown). The specificity of the interaction(s) of H-⌬N32 and H-⌬N32⌬C130 with UDP-hexanolamine-agarose was investigated by preincubating both molecules with either 2 mM UDP or 50 mM GDP before adding the resin. Fig. 4B shows that whereas GDP had no effect (data not shown), UDP completely blocked the binding of both molecules to UDP-hexanolamine-agarose, suggesting that the binding of both H-⌬N32 and H-⌬N32⌬C130 is specific for the UDP moiety on the resin. Taken together, these results suggest that the C-terminal deletion mutant proteins retain the capacity for UDP-binding, although they lack enzymatic activity.
Next, we compared the acceptor binding activity of H-⌬N32 and H-⌬N32⌬C130. Medium containing either recombinant protein was mixed with apomucin-Sepharose. The apomucinresins were treated as described above for UDP-hexanolamineagarose, except that the buffers contained 0.25 mM UDP. H-⌬N32 bound quite avidly to apomucin (Fig. 4C) . Most of the H-⌬N32 added to the apomucin matrix was recovered in the were expressed in Sf9 cells, and the recombinant proteins in the conditioned medium were fractionated as described under "Experimental Procedures." In the control experiments, H-⌬N32 and H-⌬N32⌬C130 were incubated with either 2 mM UDP or 50 mM GDP before mixing with UDP-hexanolamineagarose. The His/HA-tagged proteins recovered in the bound and unbound fractions were immunoprecipitated with an anti-His 6 tag antibody. The immunoprecipitated proteins were separated on SDS-PAGE and blotted to a polyvinylidene difluoride membrane. The His/HAtagged proteins on the membrane were probed with an anti-HA-antibody (3F10) conjugated to peroxidase and detected with an ECL Western blotting analysis system. C, binding of the His/HA-tagged proteins to apomucin-Sepharose. Binding assays were carried out as described for B except that apomucin-Sepharose was used instead of UDP-hexanolamine-agarose and the buffers contained 0.25 mM UDP. Control experiments were carried out in the absence of UDP.
EDTA and SDS-PAGE sample buffer eluates. H-⌬N32 recovered in the unbound fraction was enzymatically inactive, suggesting that all enzymatically active molecules bound to the matrix. H-⌬N32⌬C130 also bound to apomucin-Sepharose, although with significantly lower affinity. Bound H-⌬N32⌬C130 was for the most part recovered in the EDTA eluate and in the wash fraction. None of the protein was recovered in the SDS-PAGE sample buffer eluate. It should be noted that both H-⌬N32 and H-⌬N32⌬C130 required UDP for binding to apomucin. Without UDP, both failed to bind and were recovered exclusively in the unbound fractions (Fig. 4C ). It appears likely that the binding of UDP produces a change in the conformation of the catalytic domain that allows binding to apomucin. The lectin domain appears not to be involved in this conformational change.
Together with the experiments described above, these results suggest that H-⌬N32⌬C130, although enzymatically inactive, retains the capacity to bind to both UDP and apomucin. Consequently, deletion of the lectin domain from GalNAc-T1 apparently does not cause significant change in the overall conformation of the catalytic domain of the enzyme. The data also indicate that the catalytic domain in itself may be sufficient for binding to the substrates and that the interaction of the enzyme with the acceptor substrate (apomucin) was based on the protein-protein interaction, since the mutant, H-⌬N32⌬C130, in which the entire (QXW) 3 domain is deleted, was capable of binding with apomucin. The reason for the weaker binding of H-⌬N32⌬C130 to apomucin and UDP, as compared with H-⌬N32, is not clear, but it may be related to the specific interactions between the catalytic and lectin domains of the molecule, as described under "Discussion."
Characterization of the (QXW) 3 Mutants- Fig. 5 shows a comparison of the amino acid sequences of ricin and GalNAc-T1 (QXW) 3 repeats. X-ray crystallography studies of the ricin (QXW) 3 repeats have demonstrated that they contain two independent active domains (1␣ and 2␥), both of which are capable of binding lactose (21, 22) . In these domains, the haptenic monosaccharide galactose is located in a cleft, in which conserved hydrophobic residues contribute to form a compact hydrophobic core. In the ricin 1␣ domain (Fig. 5A) (21, 22) . Although the sequence identities are modest between the (QXW) 3 repeats of GalNAc-T1 and ricin, threading methods predict both molecules to have similar globular conformations (20, 24) . Judging from the structure of ricin, the ␣ repeat, of the three repeats in GalNAc-T1, is most likely to have sugar binding activity, since this unit contains all amino acid residues required for the sugar binding and the hydrophobic core formation, with the exception of Gly 455 (Fig. 5B) . We investigated the role of the GalNAc-T1 ␣ repeat unit using site-directed mutagenesis of amino acids corresponding to residues identified as being involved in ligand binding in ricin. We mutated the possible sugar-binding sites, Asp 444 , Phe 457 , Asn 465 , and Gln 466 of P-⌬N42, into alanine. We also mutated Gly 455 into glutamine such that the mutated ␣ repeat unit would have sugar-binding sites identical to those in ricin. Phe 468 , a residue putatively essential for the hydrophobic core structure, was also mutated. Three different mutations (F468W, F468Y, and F468A) were generated at this site. F468W and F468Y represent conservative amino acid replacements, whereas F468A is expected to result in disruption of the hydrophobic core due to loss of the aromatic ring and also to cause a conformational change in the repeat domain. All mutant sequences were expressed in COS7 cells, and the activities of the mutant enzymes were determined using apomucin or the synthetic peptide, PPDAATA-APL, as acceptors. PPDAATAAPL, which represents a modification of an O-glycosylated sequence in erythropoietin, contains a single glycosylation site. The peptide is a very efficient acceptor for GalNAc-T1, exhibiting a K m value of ϳ0.20 mM (2).
The enzymes with single point mutations at the putative sugar binding sites (Fig. 6A) were secreted into the medium, to the same extent as P-⌬N42, suggesting that the mutated sites had little impact on the secretion and stability of the molecules. Moreover, the activity when using the peptide PPDAATAAPL was essentially unaffected. On the other hand, the relative activities of the mutant enzymes when using apomucin as acceptor were significantly decreased compared with the parent molecules. Asp 444 appears most important among the putative sugar binding sites in the ␣ repeat domain, since, among the mutant enzymes, apomucin glycosylation by D444A was most severely impaired. The aspartate residues in the ␤ and ␥ repeats, Asp 484 and Asp 525 , corresponding to Asp 444 in the ␣ repeat, are also conserved (Fig. 5) suggesting a possible role for these residues in the binding to apomucin. To investigate this possibility, we prepared another mutant enzyme, D444A/ D484A/D525A. In this molecule, Asp 444 as well as the corresponding aspartate residues in the ␤ and ␥ repeats are mutated to alanine. Fig. 6A shows that the activity of the enzyme containing these mutations, at 25% the activity of P-⌬N42, was significantly lower than that of D444A. Moreover, the mutant enzyme glycosylated the peptide acceptor as efficiently as the wild type enzyme. These results suggest that each of the (QXW) 3 repeats interacts cooperatively with acceptors with multiple acceptor sites.
Taken together, the data indicate that the observed partial decrease in apomucin O-glycosylation by the mutant enzymes may be attributed to biased O-glycosylation of the acceptor sites in apomucin rather than to an overall decrease in glycosylation efficiency, since the peptide acceptor PPDAATAAPL was glycosylated at similar efficiency by both the wild type and mutant enzymes; i.e. it appears that the mutant enzymes are capable of glycosylating some sites in apomucin as efficiently as the wild type, whereas other sites are glycosylated at a slower rate or not at all.
Mutation at Phe 468 strongly influenced both the expression level and activity of the mutant enzymes (Fig. 6B) . In contrast to the enzymes with conservative amino acid replacements (F468W and F468Y) , the expression of F468A was significantly decreased, and its enzymatic activity, using either acceptor, was reduced to almost background level. The presence of an aromatic group appears to be essential at position 468, as predicted by its role in the hydrophobic core formation of the lectin domain (24) . The inactivation of GalNAc-T1 resulting from site-directed mutagenesis as well as the C-terminal deletions is probably caused by conformational changes in the (QXW) 3 repeats.
We also assayed the activities of the mutant enzymes used in the experiments shown in Figs. 1-4 with the acceptor peptide PPDAATAAPL. The fully active mutants, P-⌬N42⌬C1 and P-⌬N42⌬C3 (Fig. 2) , glycosylated the peptide as efficiently as (the nearly wild-type enzyme) P-⌬N42. By contrast, the mutant enzymes incapable of glycosylating apomucin (P-⌬N42⌬C12, P-⌬N42⌬C45, P-⌬N42⌬C85, P-⌬N42⌬C130, H-⌬N32⌬C130, and all of the cysteine mutants) showed no activity with the peptide acceptor. P-⌬N42⌬C9 (Fig. 2) glycosylated the peptide as efficiently as apomucin, having ϳ55% of the efficiency of P-⌬N42. The coincident loss of activity with apomucin and the peptide acceptor suggests a conformational change in the lectin domain of the mutant enzymes.
To evaluate the potential involvement of the (QXW) 3 repeats in catalysis, kinetic analysis was carried out on the mutant enzymes ( Table I ). All of the mutant enzymes generated K m values for UDP-GalNAc that were almost identical to that of P-⌬N42, despite the fact that the mutations were located at potential sugar-binding sites in the repeats. The sugar binding activity of the (QXW) 3 repeats appears, therefore, to be involved in acceptor recognition rather than in the binding to the sugar donor. Consistent with this, the affinity of the mutant enzymes for apomucin was significantly decreased (Table I) . There was a clear correlation between the affinity for apomucin and the acceptor activity of this protein (Table I and Fig. 6A) . Of the mutant enzymes tested, D444A and D444A/D484A/ D525A showed a marked increase (ϳ8-and 23-fold, respectively) in their K m values for apomucin. The (QXW) 3 repeats, therefore, appear to be involved in the binding of acceptors with multiple glycosylation sites. It appears possible that the lectin domain promotes the glycosylation of polypeptides with multiple acceptor sites by recognizing GalNAc residues at adjacent sites on the acceptor. Since apomucin does not contain any detectable GalNAc residues, the lectin domain of the enzyme must interact with GalNAc residues transferred to apomucin in the course of the reaction.
Each Repeat in the Lectin Domain Cooperatively Interacts with GalNAc on the Acceptor-In order to further investigate the role of the (QXW) 3 repeats in the recognition of apomucin, the influence of monosaccharides on the GalNAc-T1 activity was examined. In a previous report, we demonstrated that micromolar concentrations of free GalNAc do not inhibit GalNAc-T1 catalyzed glycosylation (2). However, a high concentration of GalNAc was recently shown to inhibit GalNAc-T4, a follow-up type isozyme that requires the prior O-glycosylation of the acceptor polypeptides (26) . To investigate whether GalNAc-T1 was similarly affected by high sugar concentrations, we studied the effect of 300 mM monosaccharides on the activity of P-⌬N42. In reactions using apomucin as acceptor (Fig. 7A) , GalNAc was a quite potent inhibitor. Approximately 80% of the GalNAc incorporation into apomucin was inhibited. By contrast, Gal, Glc, GlcNAc, Man, and Fuc had no significant inhibitory activity. The inhibition of P-⌬N42 by GalNAc was concentration-dependent, generating an apparent K i of 68 mM (Fig. 8) . This is almost as efficient as the reported inhibition of GalNAc-T4 by this sugar (K i ϭ 50 mM) (26) . Interestingly, the inhibitory effect of free GalNAc was entirely dependent on the type of acceptor used. When PPDAATAAPL was used, there was no measurable inhibition by GalNAc (or any of the other monosaccharides tested) (Fig. 7B) . This indicates that GalNAc-T1 has two activities that can be distinguished by the inhibition with free GalNAc (i.e. one activity is sensitive to the inhibition, and the other is resistant). In our experiments, the former activity is represented by the O-glycosylation of apomucin that contains multiple glycosylation sites, and the latter is represented by the single-acceptor site peptide. To confirm the involvement of the lectin domain in the GalNAc sensitivity of GalNAc-T1, analogous experiments were carried out with the two (QXW) 3 mutants, D444A and D444A/D484A/D525A. As FIG. 6 . Activity of enzymes containing mutations in the (QXW) 3 repeats. Enzyme activity measurements and Western blotting of mutant proteins were carried out as described in the legend to Fig. 1 . Solid and hatched bars indicate enzymatic activity determined using apomucin and PPDAATAAPL as acceptor, respectively. A, enzymes containing mutations at the putative sugar binding sites. B, enzymes containing mutations of the putative amino acid required for formation of the hydrophobic core. The Lectin Domain-dependent O-Glycosylation by GalNAc-T1discussed above, both mutant enzymes display only moderate activity toward apomucin ( Fig. 6A and Table I ). The glycosylation of apomucin was affected significantly (Fig. 7A) . Again, only GalNAc, of the monosaccharides tested, was effective. And, as expected, the GalNAc inhibition was correlated with the extent of mutations in the lectin domain; D444A/D484A/ D525A was more resistant to inhibition than D444A (Fig. 7A ).
In analogy with P-⌬N42, the inhibition of D444A by GalNAc was concentration-dependent ( Fig. 8) , with a K i value of 173 mM. This is 2.5-fold higher than that (68 mM) of P-⌬N42. The very low affinity of D444A/D484A/D525A for GalNAc made determination of an inhibition constant difficult. The triple mutant enzyme retained 70% of its activity toward apomucin even in the presence of 300 mM GalNAc (Figs. 7A and 8) . By contrast, when assayed with the peptide PPDAATAAPL (Fig.  7B) , no inhibition by monosaccharides was observed for either mutant (Fig. 7B) . We also investigated the inhibition by GalNAc, using another single acceptor site peptide, GVVPTVVPG. This peptide is also an efficient acceptor, with a K m value of ϳ0.80 mM. Again, the peptide was glycosylated at a similar efficiency by both the parent and mutant enzymes, and no significant inhibition by GalNAc was observed (Fig. 7C) . Taken together, the data clearly suggest that the lectin domain of GalNAc-T1 is involved in glycosylation of substrates with multiple acceptor sites such as apomucin. GalNAc-T1, appears to recognize GalNAc residues on the acceptor polypeptides that in situ may have been transferred by GalNAc-T1 itself or another GalNAc-transferase. Moreover, each repeat in the lectin domain functions in a cooperative manner in the recognition of GalNAc residues on acceptor polypeptides.
DISCUSSION
This report demonstrates a measurable function for the (putative) lectin domain on GalNAc-T1. Our results suggest that GalNAc-T1 catalyzes two distinct reactions. One is the initial O-glycosylation of unglycosylated polypeptide acceptors (Figs. 6 and 7). This reaction is independent of the (QXW) 3 repeats and is not inhibitable by free GalNAc. Consequently, the substrate specificity of this reaction would be determined predominantly by information in the acceptor polypeptides, such as the primary and secondary structures (2, 37) . The other reaction is a follow-up glycosylation (Figs. 6 -8 ). This would be dependent on the lectin activity of the (QXW) 3 repeats and, as a consequence, inhibitable by GalNAc. The follow-up glycosylation would be significantly influenced by the structure of the acceptor polypeptides and their degree of glycosylation (26, 27, 38 -41) . The addition of ␤1,3Gal to GalNAc would inhibit the follow-up reaction, since Gal is not recognized by the (QXW) 3 repeats (Fig. 7) . A similar binding specificity has been observed for GalNAc-T4 (26, 27) .
Considering the possible role of the (QXW) 3 repeats, O-glycosylation of polypeptides with multiple acceptor sites by GalNAc-T1 is expected to proceed in the following manner. 1) As reported in a previous paper, the reaction is initiated by the binding of the enzyme to UDP-GalNAc (2). 2) This binding brings about conformational changes in GalNAc-T1, enabling it to bind to acceptor polypeptides. The requirement of UDP for the binding of H-⌬N32 and H-⌬N32⌬C130 with apomucinSepharose (Fig. 4C) and results from previous work are consistent with this idea (2, 30) . 3) GalNAc-T1 then recognizes the acceptor polypeptide via protein-protein interaction, as is demonstrated by the binding of the lectin domain deletion mutant, H-⌬N32⌬C130, to apomucin-Sepharose (Fig. 4C). 4) The enzyme then transfers GalNAc residues to the acceptor by the initial O-glycosylation activity. 5) Following the initial glycosylation reaction, the glycosylated acceptor would be dissociated from the enzyme. This is essential for the recycling of the FIG. 7 . Inhibition of enzymatic activity by free monosaccharides. The inhibitory activity of monosaccharides was determined using apomucin (A), PPDAATAAPL (B), and GVVPTVVPG (C) as acceptors. The enzymatic activity of the recombinant proteins is expressed as relative to the activity determined in the absence of added monosaccharides. Solid bars denote the activity of P-⌬N42; gray and white bars denote that of the mutant enzymes D444A and D444A/D484A/D525A, respectively. 3 repeat domain with free GalNAc. The recombinant enzymes were expressed in COS7 cells and purified from the conditioned medium on IgG-Sepharose. The enzymatic activity of the mutant proteins was assayed in the presence of increasing concentrations of free GalNAc. Apomucin was used as acceptor. Closed squares, P-⌬N42; closed circles, D444A; closed triangles, D444A/D484A/D525A. enzyme and for the subsequent glycosylation of substrates. 6) The glycosylated acceptor may then be recognized by the lectin domain of GalNAc-T1 through protein-carbohydrate interaction. Concomitant protein-protein interaction would make the binding between glycosylated acceptors and the enzyme more stable. The importance of the carbohydrate-protein interaction is demonstrated by the reduced glycosylation of apomucin by the mutants with alterations at the putative sugar-binding sites (Fig. 6A and Table I ). 7) The enzyme would transfer GalNAc to the glycosylated acceptor (i.e. function as a follow-up enzyme). The addition of free GalNAc to the reaction mixture would interfere with binding of the enzyme to glycosylated acceptors, causing inhibition of the follow-up O-glycosylation. Consequently, it appears possible that the enzymatic activity remaining in the presence of high concentration of GalNAc represents the initial O-glycosylation activity of GalNAc-T1 (Figs. 7 and 8) .
FIG. 8. Inhibition of enzymes containing mutations in the (QXW)
It is noteworthy that truncation of either of the three (QXW) 3 repeats (Fig. 1) as well as mutations causing conformational changes in the lectin domain (Figs. 3 and 6B ) completely ablated the enzymatic activity of GalNAc-T1, despite data suggesting that the lectin domain is involved in follow-up glycosylation only. Follow-up glycosylation is expected to occur at acceptor sites located in close proximity to the initially glycosylated sites in the acceptor, since follow-up O-glycosylation can be assayed with relatively short synthetic peptides (26, 27, 38, 40, 41) . Hence, it appears reasonable to assume interaction between the catalytic and lectin domains of GalNAc-T1. This may be required to bring the two domains close together to efficiently carry out the follow-up glycosylation reaction. Consequently, mutations, which disrupt the lectin domain structure, could influence the conformation of the catalytic domain, thereby inactivating both the initial and the follow-up activities of the enzyme. The weaker binding of the C-terminal deletion mutant to UDP-hexanolamine-agarose and apomucinSepharose is consistent with conformational changes in the catalytic domain of the molecule (Fig. 4) . By contrast, the enzymes with mutations at the putative sugar binding sites of the lectin domain could retain the native conformation of both domains. They would, therefore, lose the follow-up activity, whereas their initial activity would be essentially unchanged. Interactions between the catalytic domain and the (QXW) 3 repeats have been demonstrated in the Streptomyces olvaceovirids E-86 ␤-xylanase (42, 43) . The interaction keeps the two domains close together, and the lectin domain enables the enzyme to hydrolyze insoluble xylan despite the fact that this domain is not directly involved in catalysis (43) (44) (45) (46) . Similarly, the (QXW) 3 repeats in GalNAc-T1 may play an auxiliary role in coordination with the catalytic domain. The lectin domain of GalNAc-T1 is not directly involved in the catalysis, but it is essential for presenting the glycosylated acceptor polypeptides to the catalytic domain.
This study produced new information on the structure-function relationship of the GalNAc-T1 (QXW) 3 (Fig. 6 ). In particular, we found that Asp 444 is an important site for sugar recognition (Fig. 7) . The importance of this residue and the corresponding aspartate residues in the other two repeat units is also demonstrated by the enhanced resistance to GalNAc inhibition in the triple mutant, D444A/D484A/D525A. These results indicate a cooperative mechanism in the function of the three repeat units. Interestingly, G455Q, in which glutamine is substituted for Gly 455 , such that a ricin-like Gal-binding site is introduced into the ␣ repeat of GalNAc-T1, did not confer detectable Gal binding activity to the mutant enzyme. 2 Instead, this enzyme exhibited a reduced reactivity toward apomucin similar to the other mutant enzymes. The exact role of Gly 455 in GalNAc-T1 is not clear, but the reduced activity of the mutant enzyme could be the result of a local conformational change in the ␣ repeat.
The results presented in this report demonstrate the functional importance of the (QXW) 3 repeats. The data show that this domain in fact is a functioning lectin on GalNAc-T1, at least under the in vitro conditions tested. This led to the conclusion that GalNAc-T1, in addition to glycosylating unmodified polypeptides in vivo, may also specifically recognize and glycosylate partially glycosylated acceptors. The results generated in this study also provide new information about the substrate specificity of GalNAc-T1. Although acceptor specificities of the GalNAc-transferases have been studied quite extensively, a specific consensus sequence has not been identified for any enzyme (2, 47) . Instead, GalNAc-T1 is regarded as a multisubstrate enzyme with broad acceptor specificity. Still, the sequence context surrounding glycosylated serine and threonine residues is known to be important. Certain residues, at certain positions, in the vicinity of the acceptor amino acid are known to promote glycosylation, whereas other residues are known to be refractory. Based on this information, computerbased algorithms have been generated capable of predicting O-glycosylation, with an accuracy of ϳ80% (47, 48) . The difficulty in exactly defining the substrate specificity may in part be ascribed to the multiple functions of GalNAc-transferases, as demonstrated by the two activities of GalNAc-T1. Discrimination between these two activities could lead to a more in-depth understanding of the molecular mechanism of this enzyme. By introducing multiple mutations in the (QXW) 3 repeats, we are currently preparing novel recombinant enzymes that retain only the initial O-glycosylation activity. More detailed structural information on the lectin domain would open the possibility of designing novel enzymes with the altered (follow-up) substrate specificity.
